Placating Turkey, Trump admin says doesn’t recognize Armenian genocide

President Donald Trump shakes hands with Turkish President Recep Tayyip Erdogan during a news conference in the East Room of the White House in Washington. (AP Photo)
Short Url
Updated 18 December 2019

Placating Turkey, Trump admin says doesn’t recognize Armenian genocide

  • Armenia says that 1.5 million were killed in an effort to wipe out the Christian ethnic group in the waning days of the Ottoman Empire
  • Turkey puts the number far lower and adamantly rejects the term genocide, saying that Turks also died in what it considers fighting as part of First World War

WASHINGTON: President Donald Trump’s administration said Tuesday it does not consider the mass killings of Armenians in 1915 to be genocide, seeking to placate Turkey which was angered that the US Congress recognized it as such.
“The position of the administration has not changed” after the votes by Congress, State Department spokeswoman Morgan Ortagus said in a terse statement.
“Our views are reflected in the president’s definitive statement on this issue from last April,” she said.
In the statement on the mass killings’ anniversary, Trump said the United States honored victims of “one of the worst mass atrocities of the 20th century” but did not use the word genocide.
He instead encouraged Armenians and Turks to “acknowledge and reckon with their painful history.”
Armenia says that 1.5 million were killed in an effort to wipe out the Christian ethnic group in the waning days of the Ottoman Empire, the forerunner of modern-day Turkey.
Turkey puts the number far lower and adamantly rejects the term genocide, saying that Turks also died in what it considers fighting as part of First World War.
Turkey last week summoned the US ambassador to Ankara, David Satterfield, after the Senate followed the House of Representatives in recognizing the killings as genocide.
The Senate and House resolutions, both passed overwhelmingly, said it was the policy of the United States “to commemorate the Armenian genocide through official recognition and remembrance.”
But the so-called simple resolutions, unlike laws passed by Congress, do not have the force of law or require the president’s signature, meaning that the administration still has significant leeway in how to proceed.
Senator Robert Menendez, the top Democrat on the Senate Foreign Relations Committee who spearheaded the resolution denounced Trump and Secretary of State Mike Pompeo as being “on the wrong side of history.”
“While not surprising, I am still deeply disappointed that both President Trump and Secretary Pompeo have yet to find their moral compass on this issue, and that they insist on allowing Turkey to have a veto on our own domestic decision,” Menendez said.
“It’s time for this nation to recognize the truth. We must honor those who lost their lives in the Armenian genocide, remember how they died and pledge ourselves to change the way history remembers their deaths,” he said.
Allies of Trump had initially tried to block the resolutions in Congress in hopes of preserving relations with Turkish President Recep Tayyip Erdogan.
During a meeting in Washington last month, Trump said he was a “big fan” of Erdogan despite wide criticism in Congress over his human rights record and his incursion into Syria to fight Kurdish fighters formerly allied with Washington.
Trump has also held off on sanctions urged by Congress over the NATO ally’s purchase of Russia’s S-400 missile defense system.
Previous presidents have also struggled with how to address the events of 1915, with the Armenian-American community pushing hard for genocide recognition.
Barack Obama as a candidate promised to recognize the genocide but after his election did not use the word, instead saying that he stood by his pre-White House views.
Some 30 countries recognize the Armenian genocide, with several European nations criminalizing denial.


US to pay over $1bn for 100m doses of J&J’s potential COVID-19 vaccine

Updated 42 min 3 sec ago

US to pay over $1bn for 100m doses of J&J’s potential COVID-19 vaccine

  • The latest contract equates to roughly $10 per vaccine dose produced by J&J
  • This is J&J’s first deal to supply its investigational vaccine to a country

WASHINGTON: The United States government will pay Johnson & Johnson over $1 billion for 100 million doses of its potential coronavirus vaccine, its latest such arrangement as the race to tame the pandemic intensifies, the drugmaker said on Wednesday.
It said it would deliver the vaccine to the Biomedical Advanced Research and Development Authority (BARDA) on a not-for-profit basis to be used after approval or emergency use authorization by the US Food and Drug Administration (FDA).
J&J has already received $1 billion in funding from the US government — BARDA agreed in March to provide that money for the company to build manufacturing capacity for more than 1 billion doses of the experimental vaccine.
The latest contract equates to roughly $10 per vaccine dose produced by J&J. Including the first $1 billion deal with the USgovernment, the price would be slightly higher than the $19.50 per dose that the United States is paying for the vaccine being developed by Pfizer Inc. and German biotech BioNTech SE.
The US government may also purchase an additional 200 million doses under a subsequent agreement. J&J did not disclose that deal’s value.
J&J plans to study a one- or two-dose regimen of the vaccine in parallel later this year. A single-shot regimen could allow more people to be vaccinated with the same number of doses and would sidestep issues around getting people to come back for their second dose.
This is J&J’s first deal to supply its investigational vaccine to a country. Talks are underway with the European Union, but no deal has yet been reached.
J&J’s investigational vaccine is currently being tested on healthy volunteers in the United States and Belgium in an early-stage study.
There are currently no approved vaccines for COVID-19. More than 20 are in clinical trials.